Gold and silver prices rose on MCX on September 18, recovering from volatility after the US Fed’s rate decision. A softer US dollar and easing…

Bernstein said Novartis’ decision to discontinue VHB937 for amyotrophic lateral sclerosis (ALS) on September 16 improves the commercial landscape for Zydus Lifesciences’ Usnoflast.

Supreme Court allowed SEBI and NSE settlement in co-location and dark-fibre cases, ending NSE’s decade-old regulatory issues.

Last month, BEML chairman and managing director Shantanu Roy told CNBC-TV18 that the company is expecting a stronger performance in this fiscal and he projected…

Under the agreement, Dr Reddy’s will have exclusive responsibility for the marketing and distribution of Qdenga in India’s private market. Takeda will retain commercialisation rights…

Deven Choksey of DRChoksey Finserv expects Tata Sons to list eventually, naming Tata Chemicals as the top beneficiary. He also backs the NSE IPO for…

Abneesh Roy, Executive Director at Nuvama Institutional Equities, expects Hindustan Unilever (HUL) to maintain its near-term EBITDA margin guidance of 22.5-23.5%, although he sees the…

Sandeep Tandon of Quant Mutual Fund says yen appreciation and rising developed-market yields, not Indian fundamentals, are the biggest risk to markets over the next…

Bank of Japan raised its benchmark interest rate by 25 basis points to 1.25%, highest since 1995, with a 7-2 vote. Underlying inflation nears 2%.…

Noel Tata’s tabled the proposal received from the SP Group at the Tata Sons board meeting on Thursday. It followed discussions between Noel Tata, SP…